Schedule 13D ownership disclosure
CARA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 140755109
Event date: 2024-12-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vifor (International) Ltd.Reported CIK 0001675217
Shares: 7,396,770 · Class: 13.5%
- CSL Limited
Shares: 7,396,770 · Class: 13.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-24-137983
- Form type
- SCHEDULE 13D/A
- Filer
- Tvardi Therapeutics, Inc.
- CIK
- CIK 1346830
- Filed
- Dec 18, 2024
- Reporting period
- Dec 17, 2024
- Description
- Schedule 13D beneficial ownership